Considering that chordoma is histologically characterized by a rich myxoid stroma (45), these data strongly indicate that CAFs expressing B7H3 induce an inhibitory immune microenvironment to promote chordoma progression, thereby leading to adverse patient outcomes. Here, CD276 is linked to chordoma.